Abstract
BackgroundSo far, for IgG4-related disease, no randomised clinical trials concerning therapy are published. Corticosteroids are considered the first-line treatment and most patients respond promptly to steroids. However, recurrent or refractory...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have